Gregory A. Gould
Equibles does not estimate personal net worth.
Get an email with a short summary when Aytu Biopharma, Inc publishes a filing, an earnings call transcript or a press release.
Get AYTU alertsAbout Gregory A. Gould
Gregory A. Gould is recorded as CFO at Aytu Biopharma, Inc (AYTU). The proxy statement of Aytu Biopharma, Inc reports total compensation of $96,000 for Gregory A. Gould in fiscal 2018, including a base salary of $96,000. Disclosed compensation is on record for 2 fiscal years. Aytu Biopharma, Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Aytu Biopharma, Inc includes Joshua R. Disbrow (CEO and Board Member), John A. Donofrio, Jr. (Chairman), Ryan Selhorn (CFO) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at Aytu Biopharma, Inc
- Joshua R. Disbrow CEO, Board Member
- John A. Donofrio, Jr. Chairman
- Ryan Selhorn CFO
- Christopher Brooke COO
- Abhinav Jain Board Member
- Beth Hecht Board Member
- Beth P. Hecht Board Member
- Carl C. Dockery Board Member
- Gerald McLaughlin Board Member
- John A. Donofrio Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Aytu Biopharma, Inc (AYTU) | Chief Financial Officer | — | — |
| 2018 | Aytu Biopharma, Inc (AYTU) | Chief Financial Officer | $96,000 | $96,000 |
Recent activity
No call appearances or filed executive changes recorded yet.